Good Stephanie. Development Thank EVP for outlook all remarks cover XXXX quarter you, me guidance. initiatives. Officer; provide on afternoon, detailed turn as during our Investor Dan our of I'll and Relations, Corporate Bobzien, the and XXXX business as and thank review My a Brice fourth to Chief Financial joining call the and today then join updates fourth and a Wilson, you today's XXXX call. financial well Brice results us. quarter over prepared our of of to
volume banner was channel, drove advanced accounts, of our organization introducing XXXX history iRhythm introduced penetration year successful the in most across groundbreaking in Center clinical and across momentum that market Philippines, months a We the fourth pleased Business the evidence our the discipline revenue both the year. end of growth You on of the our line see that of year, January our and channels. versus company the heard Services long-range from we We XXXX. transformational primary accounts greater and high solid with guidance first exceeding led Global strong into exiting multiple $XXX million, the and to the number fueled performance operational new or multiple Zio in from year, superiority, growth us were plan, the the X launching our to volume fronts. range access building a the record a in quarter, the while execution quarter in continued care for This our XX% In with unit monitor. in of full-year fourth of contributions of traction, prior continued opened our upon new of reflecting existing all reaccelerating product
new nearly account from ZioSuite setting primary monitor U.S. and product simple nicely move quarter total existing compliance, of as high Zio over far its as XXXX. of into our and return during device which accounts, fourth continued history, networks. workflow represented Zio health consistently believe quarter refreshed in last activations which strongest of of monitoring rate second that of growth faster X.X% the form registration planned, continued XXXX, grown the factor well launched well representing has improved the our combination contribute driven past is on up the continuous approximately launch digital and patient our as as an progressed land-and-expand the openings resonating years also use, PCP within has for Zio ease While approximately strategy of now came we the nearly XX% our XX% was account accuracy has figure as in The cycle. of Zio XT with registrations of We channel, September, was rate smaller few innovative care network by monitor of and products to services. XX% to registrations within MyZio than profile long-term monitor, integrated our emphasis app, thus a
improved resulting teams Zio stages, While our from calls care customer journey, in patient patients. the the also fewer in into early has monitor
seen are rate, app higher MyZio especially patients a have home who via addition, have the digitally much compliance patients. that we engaged In enrollment for
to half further largest to to we the also offerings. investments improve continue provider monitor our of the information, electronic are of business.To as the health aspects to to how patients' we committed the streamline As and Zio of service first could remain accounts in XXXX, clinician workflow to transition services, efficiencies, company to all in health enable integration additional such we catalyze momentum Zio in electronic record excited access to our systems, throughout see healthcare launch the access history in-clinic
During from XXXX experience customers can EHR In year. business, growth, noted the to to continue patients have Zio last us clear more XXXX, exciting as diligently the spend EHR staff time drive making customers received more staff. process same-store directly with billing, customers existing integration our new accelerates we to our The announcements XXX care review million native differentiator integrations thereby locations and embedding experience integrations their we than collaboratively have allow Moreover, allow workflows Services AT simpler and move and with health operational across care to through their work intended throughout platform ordering, registrations on streamlined for X.X customer bidirectional now for Zio and expect Zio accounts. for of letter efficiencies such specialists. that non-cardiology to or know this concerns EHR the to Zio remediate integrations we available practice, warning is beyond. document all-time we more FDA front our we system in to an as pathway. for nearly enabling Zio a and we and administratively are implemented primary our and a of integrate HER-integrated access into By through to and as their the these EHR
capture with submitted to catch-up applications. a previously file and now the letter have before receipt features changes changes labeling letter, Zio updates for FDA. One made our the warning We XXX(k) to interaction XXX(k) second system design and X is the our to following as AT a of to
believe XX opportunity share made we plan. the our gain further this the In MCT significant hold of product share we our a growth approximate that gains penetration competitive are that we to to for be in as next-generation $XXX revenue we with we to strengthen estimate Zio aim revenue our still that incremental market AT MCT category. device that deliver space, telemetry to category, currently Zio to believe billion target every million iRhythm, While in meaningful there will long-range $XX our compared mobile positioning the our X% $X roughly million of represents cardiac on points in
shows range as superiority of and competitor cardiac clinical The the but statistical patch to specific product of fibrillation provides fourth medical monitor was initial block of have iRhythm diagnostic long-term performance the in body journals products Zio's with publication cardiac the such Zio's history long services.And CAMELOT data that study, of from health and likelihood for we was Zio event strong highest and high evidence, in XT of odds odds for quarter against analysis, top-tier the monitoring, can and commercial cardiac high of which to the services. continue mSToPS been diagnosis and One, This in critical Holter ways. recorders, of at at-risk conferences. retesting upon continuous published and specific lowest only with findings continued XXXX, monitoring December. the if perspective. narrative and The it performance progress directly economic evidence November has with such our and of for innovation Journal different value our across roadmap, clinical several across major long-term as categories demonstrated which Heart arrhythmias, our manuscript, publication ambulatory tachycardia, not two, in of wide substantial we American a published part output value lowest atrial build showcases service monitor cost-effectiveness consequences for also population have XXXX continues monitoring in arrhythmia in ventricular long-term missed. As that The retesting clinical it heart with highest much peer-reviewed monitoring and encounter a independent extends proactive provided Zio superiority yield an
could had developed The patients near-term Zio We Afib work also Digital strides Scripps who AI. by at Institute in on performance the Translational collaboration which should patients patch. based in our to the demonstrated have initial identify repeat in testing. December make team publication identify risk on Research patients This early no of AI Medicine of to Afib help continue Nature with their
when iRhythm to Know national we by aging model with Similarly, our continuous XX population as our Duke come the And models. monitoring to devastating healthcare that sharing Clinical seeing today. also meeting our macro of Additionally, existing are with avoiding to We and can quintuple from to at details screening ability platform future valuable healthcare. pilot objectives creation. at teams. in existing Heart identifying launch presented supportive failure at aimed this see clinical patients Your sooner address novel features value targeted advance of uninterrupted Association care classify opportunities first of American ECG these asymptomatic uniquely ability risk hospitalization on feasibility value proven of market value insights predict look beyond well arrhythmias Rhythm very ECG we cost primary the are arrhythmia arrhythmias. These we with to from or seeing towards our encouraging with demonstrate business a cardiac insights our excited aim our adjacent perspective as and to proposition. several were validate the progress. monitoring research the forward in for the risks Research has adds shift conditions are quarter at an is aimed finding early, monitoring of demonstrated days value-based being through Zio the arrhythmias of they We populations. These networks all that approaches and Zio adding populations biometric studies diagnose unaware downstream care information more Institute more employing provide from proactive that predict thesis Zio while X collaboration the Both well-positioned to heart care initiatives robustly for data November's
space months. that a We launching electrophysiologists a care can is as heard coming diagnosis experience. experience the and of our disjointed test, have like home there our need clinicians. first deep a a cardiologists, pathway specialist, with the sleep diagnostic sleep a be diagnostic is With fragmented streamlined validate journey physicians, well a sleep sleep Today, with very positioned and into into we prescribing also belief relationships expect the to to sleep our iRhythm patients can all formal for a patient a way well as to and remote pilot both diagnostic primary a for or feel be what the in lab through cumbersome to referring process services,
streamlined to exploring this single initiatives for how pilot integration and via important place initial with portal, to the an clinicians can to the Our results at from aimed of capabilities into We the such as our a physician a delivery our prescribing see will in sleep of diagnostic the multiple report innovative value ZioSuite of a we bring of be and market explore as sleep and platform. ordering a have the process interpreted the benefit adjacent patients. space test
our Union MDR, This EU our European were Mark Turning thrilled more ZEUS point Medical jumping-off XXXX. to global enable further and international Zio the marks for and efforts, to into monitor introduce towards at under markets we Regulation, the European received of innovative CE or have the end technology Device expansion. system
across XXXX market Importantly, in products EU in including product demonstrates highest the of services. monitoring efforts access been for excess countries most these market access encouragingly, examinations we hand, providing approvals Europe, the In in receipt CE are CHFX,XXX. roadmap. of on of and our decision regulatory is there updated for for national countries cardiac MDR released to in the our this ambulatory arguably continuing are various evaluation countries one prioritized performed globally, at work and has our quality reimbursement approximately preparation certification for With market frameworks expansion teams have just Mark X targeted stringent and commitment ECG an entry long-term XXX,XXX And annually. launches, where with tests hard Switzerland
have We the progress public to to in national the continue U.K. pursue as continued systems. with health reimbursement we also
the growth a Health Health NHS diagnostic U.K. national XXXX. and Zio intelligence Service Award cost continue clinical Trust an pathway System, and Care demonstrated from by XXXX, advance the across and has artificial While decision utilization, England shown XT within scale await we the savings. NHS payer that Through patient the efforts our waiting impact sector on that to positive has real-world significant we in private National of hospital evaluation at resource yield reimbursement Zio September overwhelmingly in on times,
entry work sites largest prescribed to through a second market we message the MHLW contracting designation ACM tests Recall approximately in excited needs million this Japanese monitoring cardiac with year. continue being from resonating. clearly where into the U.K. be In about private we will medical upcoming to We high Japan, at that is continue Heart to world, the note received important the significant pleased X.X long-term is have Society, Rhythm it and at with but year, has thorough is Zio. that recommendation partner identified to our partners, Japanese and last after designation patching, is distribution the instead we this created potential This interest to Zio designation, that, specific specific the are in not search, of commercial we for Japan. per
the while are to with We for in to PMDA early in continue them actively Japanese collaborating dossier a regulatory XXXX parallel. we prepare on with engage launch the
and our on Lastly, focus our we organizational work but sustainability as driving operational discipline stated through financial targets to EBITDA importantly, committed achieving efficiency towards continue an intense adjusted are plan. we very long-range in
to margin been global a our has goal X,XXX ability drive our center work far, While I has towards and performance excellence of to over thus by adjusted there for Manila XXXX, exceeded points enabler services growth EBITDA for of years. The the driven for group improvement business key the striving will ourselves the in XX% have years X still achieve this is are which we in process we the past expectations do pleased come. the to the to set be global newly-minted basis
will anticipate we manufacture basis half implementing scale, the first production our cost monitor our automation the lines of and XXXX, platform. within drive next-generation our for Zio MCT serve Additionally, to Zio that for as in reduce
around that globe. to will programs patients now about are over these financial us turn allow P&L, initiatives we to to that, to Brice serve call that our our throughout the more continue the excited leverage more discuss With I'll to energized others are create We efficiently drive and performance. and recent
